164 related articles for article (PubMed ID: 28499754)
1. Methotrexate-induced epidermal necrosis: A case series of 24 patients.
Chen TJ; Chung WH; Chen CB; Hui RC; Huang YH; Lu YT; Wang CW; Wang KH; Yang LC; Hung SI
J Am Acad Dermatol; 2017 Aug; 77(2):247-255.e2. PubMed ID: 28499754
[TBL] [Abstract][Full Text] [Related]
2. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.
Berna R; Rosenbach M; Margolis DJ; Mitra N; Baumrin E
Am J Clin Dermatol; 2022 Jul; 23(4):449-457. PubMed ID: 35486323
[TBL] [Abstract][Full Text] [Related]
4. Ulcerations due to methotrexate toxicity in a psoriasis patient.
Souza CF; Suarez OM; Silva TF; Gorenstein AC; Quintella LP; Avelleira JC
An Bras Dermatol; 2016; 91(3):375-7. PubMed ID: 27438211
[TBL] [Abstract][Full Text] [Related]
5. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole.
Yang CH; Yang LJ; Jaing TH; Chan HL
Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734
[TBL] [Abstract][Full Text] [Related]
6. Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin.
Chung WH; Chang WC; Stocker SL; Juo CG; Graham GG; Lee MH; Williams KM; Tian YC; Juan KC; Jan Wu YJ; Yang CH; Chang CJ; Lin YJ; Day RO; Hung SI
Ann Rheum Dis; 2015 Dec; 74(12):2157-64. PubMed ID: 25115449
[TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease.
Hani N; Casper C; Groth W; Krieg T; Hunzelmann N
Eur J Dermatol; 2000; 10(7):548-50. PubMed ID: 11056429
[TBL] [Abstract][Full Text] [Related]
8. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
9. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
Hocaoglu N; Atilla R; Onen F; Tuncok Y
Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate related cutaneous adverse drug reactions: a systematic literature review.
Zuber M; Harikrishna ; Vidhyashree ; Chhabra M; Venkataraman R; Kumar S; Rashid M
J Basic Clin Physiol Pharmacol; 2022 Sep; 33(5):549-565. PubMed ID: 34706401
[TBL] [Abstract][Full Text] [Related]
11. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
[TBL] [Abstract][Full Text] [Related]
12. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
[TBL] [Abstract][Full Text] [Related]
13. [Correct use of methotrexate].
Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
Ned Tijdschr Geneeskd; 2009; 153():A696. PubMed ID: 19785852
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Lipowicz S; Sekula P; Ingen-Housz-Oro S; Liss Y; Sassolas B; Dunant A; Roujeau JC; Mockenhaupt M
Br J Dermatol; 2013 Apr; 168(4):726-32. PubMed ID: 23413807
[TBL] [Abstract][Full Text] [Related]
15. [Methotrexate-induced skin detachment].
Aractingi S; Briant E; Marolleau JP; Verola O; Brice P; Dubertret L; Gisselbrecht C
Presse Med; 1992 Oct; 21(35):1668-70. PubMed ID: 1282715
[TBL] [Abstract][Full Text] [Related]
16. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of histologic features of toxic epidermal necrolysis.
Valeyrie-Allanore L; Bastuji-Garin S; Guégan S; Ortonne N; Bagot M; Roujeau JC; Revuz JE; Wechsler J; Wolkenstein P
J Am Acad Dermatol; 2013 Feb; 68(2):e29-35. PubMed ID: 22088428
[TBL] [Abstract][Full Text] [Related]
18. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate-induced toxic epidermal necrolysis in a patient with psoriasis.
Primka EJ; Camisa C
J Am Acad Dermatol; 1997 May; 36(5 Pt 2):815-8. PubMed ID: 9146556
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.
Abelson HT; Fosburg MT; Beardsley GP; Goorin AM; Gorka C; Link M; Link D
J Clin Oncol; 1983 Mar; 1(3):208-16. PubMed ID: 6607976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]